Docebo Inc. (TSE:DCBO – Get Free Report) insider Lauren Anne Tropeano sold 367 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of C$33.60, for a total value of C$12,331.20. Following the completion of the sale, the insider directly owned 2,236 shares in the company, valued at C$75,129.60. This trade represents a 14.10% decrease in their position.
Docebo Stock Performance
TSE DCBO traded down C$0.03 during trading on Tuesday, hitting C$34.89. The company’s stock had a trading volume of 14,112 shares, compared to its average volume of 103,433. Docebo Inc. has a 52 week low of C$19.87 and a 52 week high of C$42.52. The firm has a market cap of C$870.44 million, a P/E ratio of 30.34 and a beta of 0.28. The firm has a 50 day moving average price of C$30.77 and a 200 day moving average price of C$26.93. The company has a quick ratio of 3.25, a current ratio of 0.76 and a debt-to-equity ratio of -30,643.19.
Docebo (TSE:DCBO – Get Free Report) last posted its quarterly earnings data on Friday, August 7th. The company reported C$0.50 earnings per share for the quarter. The company had revenue of C$97.54 million during the quarter. Docebo had a return on equity of 114.70% and a net margin of 13.23%. Equities research analysts forecast that Docebo Inc. will post 1.6842684 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Read Our Latest Analysis on Docebo
About Docebo
Docebo (NASDAQ: DCBO; TSX: DCBO) is the enterprise platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop. Docebo gives organizations the tools to close skills gaps, develop talent, and perform at their best in an AI-driven world.
Recommended Stories
- Five stocks we like better than Docebo
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Docebo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docebo and related companies with MarketBeat.com's FREE daily email newsletter.
